Medical News

RSS

Boston Scientific to pay J&J $1.725 billion for settling three patent disputes

Boston Scientific Corporation today announced the settlement of three patent disputes with Johnson & Johnson (J&J). The disputes date back to 2003 and cover Boston Scientific's Jang patent and J&J's Palmaz and Gray patents, all of which involve intellectual property in the cardiovascular arena. Boston Scientific will make a $1.725 billion payment to J&J in connection with the settlement.

2 Feb 2010

Danaher acquires Life Technologies' mass spectrometry business

Life Technologies Corporation, a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation for $450 million in cash, subject to a conventional working capital adjustment.

From Danaher 2 Feb 2010

Some states mull requiring prescription for meth ingredients

"State and local efforts to thwart methamphetamine production by further limiting consumer access to a popular decongestant are pitting law enforcement against pharmacists and patients," USA Today reports.

2 Feb 2010

Companies may hit new anti-discrimination law when asking workers about health issues

Employers offering wellness and preventive health programs can sometimes run afoul of a new anti-discrimination law restricting their ability to ask workers about family medical histories, The Wall Street Journal reports.

2 Feb 2010

NYBC urges people to donate blood

New York Blood Center (NYBC), serving New York City, Long Island, the Hudson Valley, and New Jersey, calls upon people of diverse backgrounds to please donate blood. The need for blood is constant.

2 Feb 2010

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

Phosphagenics Limited today announced positive results from a Phase 1B clinical study using the Company’s patented TPM™ (Targeted Penetration Matrix) for the transdermal delivery of oxycodone. The results of the successful trial demonstrate that daily application of a TPM™ patch delivers therapeutic levels of oxycodone into the blood stream in a reproducible, consistent and sustained manner.

2 Feb 2010

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

2 Feb 2010

FDA and PATH collaborate to advance pneumococcal vaccine development for children

The U.S. Food and Drug Administration (FDA) today announced a collaboration with PATH to advance development of a vaccine to protect children against diseases caused by Streptococcus pneumoniae (pneumococcus), especially pneumonia.

2 Feb 2010

Response Biomedical continues global market expansion, signs Guangzhou Wondfo Biotech in China

Response Biomedical Corporation announced that the Company has signed a second partner, Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) in China to sell the Company’s diagnostic products, expanding its strategic presence in this important global market.

2 Feb 2010

IMRT and extensive safety measures can prevent radiation injuries in cancer patients, says oncology expert

Recent media stories have reported isolated cases of cancer patients who were injured by incorrect doses from intensity-modulated radiation therapy (IMRT).

2 Feb 2010

Memory loss or decline in thinking abilities may indicate higher risk of stroke

People who experience memory loss or a decline in their thinking abilities may be at higher risk of stroke, regardless of whether they have been diagnosed with dementia, according to a new study published in the February 2, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Feb 2010

Long-chain omega-3 polyunsaturated fatty acids may reduce risk of psychotic disorders

Individuals at extremely high risk of developing psychosis appear less likely to develop psychotic disorders following a 12-week course of fish oil capsules containing long-chain omega-3 polyunsaturated fatty acids, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Feb 2010

NASDAQ Panel grants NexMed extension to meet remaining listing requirements

NexMed, Inc., a specialty CRO and a developer of products based on the NexACT technology, today announced that the NASDAQ Listing Qualifications Panel (the “Panel”) has determined that NexMed has evidenced compliance with the market value of listed securities requirement for continued listing on The NASDAQ Capital Market by evidencing a market capitalization in excess of $35 million for a minimum of ten consecutive trading days, in lieu of the $2.5 million in stockholder’s equity as required by the Panel’s decision dated December 17, 2009.

2 Feb 2010

Finger and thumb injuries account for majority of pediatric traumatic amputations

According to a new study conducted by researchers at the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital, there were more than 950 cases of traumatic amputations among children aged 17 years and younger in the United States in 2003. Of these cases, finger and thumb amputations accounted for the majority of the injuries (64 percent).

2 Feb 2010

NewTom VGi mobile 3D Cone Beam CT scanner now at Illinois 3D Mobile Imaging

AFP Imaging and Deborah Vessell, owner of 3D Mobile imaging, are proud to announce the first NewTom VGi mobile 3D Cone Beam CT scanner to operate in the state of Illinois. This adds yet another mobile operation to an ever growing fleet of independently owned mobile Cone Beam CT units across the country which utilizes the NewTom VGi Cone Beam CT.

2 Feb 2010

Phase III study evaluating PEP005 Gel for treatment of AK meets primary clinical endpoint

LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.

2 Feb 2010

Genetic mutations may trigger suicidal behavior in depressed patients

Single mutations in genes involved with nerve cell formation and growth appear to be associated with the risk of attempting suicide among individuals with depression, according to a report posted online today that will appear in the April print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Feb 2010

MSU scientist discovers the process that causes retinal cells to die

Scientists have long known that high blood sugar levels from diabetes damage blood vessels in the eye, but they didn't know why or how. Now a Michigan State University scientist has discovered the process that causes retinal cells to die, which could lead to new treatments that halt the damage.

2 Feb 2010

FDA approves neurostimulation treatment for heart failure

The FDA recently approved the first study of neurostimulation as a treatment for heart failure, a chronic disease that affects nearly six million Americans and is the leading cause of hospitalization in America.

2 Feb 2010

NanoInk launches configured protein array kit from its Nano BioDiscovery Division

NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.

2 Feb 2010

Medical News

Boston Scientific to pay J&J $1.725 billion for settling three patent disputes

Danaher acquires Life Technologies' mass spectrometry business

Some states mull requiring prescription for meth ingredients

Companies may hit new anti-discrimination law when asking workers about health issues

NYBC urges people to donate blood

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

FDA and PATH collaborate to advance pneumococcal vaccine development for children

Response Biomedical continues global market expansion, signs Guangzhou Wondfo Biotech in China

IMRT and extensive safety measures can prevent radiation injuries in cancer patients, says oncology expert

Memory loss or decline in thinking abilities may indicate higher risk of stroke

Long-chain omega-3 polyunsaturated fatty acids may reduce risk of psychotic disorders

NASDAQ Panel grants NexMed extension to meet remaining listing requirements

Finger and thumb injuries account for majority of pediatric traumatic amputations

NewTom VGi mobile 3D Cone Beam CT scanner now at Illinois 3D Mobile Imaging

Phase III study evaluating PEP005 Gel for treatment of AK meets primary clinical endpoint

Genetic mutations may trigger suicidal behavior in depressed patients

MSU scientist discovers the process that causes retinal cells to die

FDA approves neurostimulation treatment for heart failure

NanoInk launches configured protein array kit from its Nano BioDiscovery Division

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News